Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Feb 19, 2007 at 6:24 AM EST

Osiris: Promising Stem Cell Research, Questionable Management

by H.S. AyoubBioHealth Investor.com While investors must research the history of any company’s management and executives, it is even more…

Douglas A. McIntyre | Feb 17, 2007 at 9:29 AM EST

Friday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INSMED INC [INSM] +16.83% ONYX PHARM INC [ONXX] +12.35% ACORDA THERAPEUTICS [ACOR] +8.54% ORTHOLOGIC CP [OLGC]…

Douglas A. McIntyre | Feb 16, 2007 at 4:12 AM EST

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology DYAX CORP [DYAX] +14.61% CYTRX CP [CYTR] +14.00% FERMAVIR PHARMACEUTL [FMVR.OB] +8.82% LIFECORE BIOMEDICA [LCBM] +6.51%…

Douglas A. McIntyre | Feb 15, 2007 at 10:11 AM EST

IPO Filing: NovaBay Pharmaceuticals

NovaBay Pharmaceuticals has filed to come public via an IPO, although this one is being put on the American Stock…

Douglas A. McIntyre | Feb 15, 2007 at 5:06 AM EST

Amgen And Genentech: Can Clinton Do What Competition Could Not?

Over the last five years, the shares of Genentech (DNA) have risen about 275%. Shares in Amgen (AMGN) are not…

Douglas A. McIntyre | Feb 15, 2007 at 3:27 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology SGX PHARMACEUTICALS [SGXP] +25.78% HALOZYME THERAPEUTIC [HTI] +11.59% FAVRILLE, INC. [FVRL] +10.41% INVITROGEN CORP [IVGN] +9.92%…

Douglas A. McIntyre | Feb 14, 2007 at 4:14 AM EST

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology ONYX PHARM INC [ONXX] +7.74% REGENERON PHARMACE [REGN] +6.86% DYAX CORP [DYAX] +6.85% PROGEN INDS LTD…

Douglas A. McIntyre | Feb 14, 2007 at 4:12 AM EST

Are NovaDel and Pfizer Collaborating on a Viagra Spray?

by H.S. AyoubBioHealth Investor.com The Business, a British business magazine, published an article early January on rumors that Pfizer (PFE)…

Douglas A. McIntyre | Feb 13, 2007 at 1:17 PM EST

Illumina’s Double Play (Revise)

Shares in Illumina (ILMN), a company that makes chips and tools for testing genetic variations, are up 5% to $36.70…

Douglas A. McIntyre | Feb 13, 2007 at 10:42 AM EST

Don’t Expect Express Scripts to Bow Out of Caremark Bidding

By Chad Brand of Peridot Capitalist Pharmacy chain CVS (CVS) has increased its bid for Caremark (CMX) by $4 per…

Douglas A. McIntyre | Feb 13, 2007 at 5:52 AM EST

Witch Doctors And Stents (BSX)(JNJ)

No matter how many studies the medical community does, it cannot come up with a solid opinion for or against…

Douglas A. McIntyre | Feb 13, 2007 at 4:09 AM EST

Monday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology ONYX PHARM INC [ONXX] +96.98% LPATH INC [LPTN.OB] +16.67% CYTORI THERAPEUTICS [CYTX] +11.42% VION PHARM INC…

Douglas A. McIntyre | Feb 13, 2007 at 4:07 AM EST

Amphastar and Teva Prevail Over Aventis, May Still Not Receive FDA Approval

by Robert S. Dailey Aventis Pharma v. Amphastar Pharms., No. 03-cv-887 (C.D. Cal. 2007) In a ruling issued last Friday,…

Douglas A. McIntyre | Feb 12, 2007 at 9:17 AM EST

Onyx Pharma Soars on Liver Cancer Drug

Onyx Pharmaceuticals (ONXX-NASDAQ) is probably as happy as you could imagine that it partnered with Bayer (BAY-NYSE/ADR). ONXX shares are…

Douglas A. McIntyre | Feb 12, 2007 at 4:13 AM EST

Raggedy Ann and the Anti-Vaccination Movement

by H.S. AyoubBioHealth Investor.com It was in 1796 that Edward Jenner successfully immunized a child against smallpox, and his experiment…

1 … 380 381 382 383 384 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Osiris: Promising Stem Cell Research, Questionable Management

Friday’s Top Biotech and Medical Stocks

Thursday’s Top Biotech and Medical Stocks

IPO Filing: NovaBay Pharmaceuticals

Amgen And Genentech: Can Clinton Do What Competition Could Not?

Wednesday’s Top Biotech and Medical Stocks

Tuesday’s Top Biotech and Medical Stocks

Are NovaDel and Pfizer Collaborating on a Viagra Spray?

Illumina’s Double Play (Revise)

Don’t Expect Express Scripts to Bow Out of Caremark Bidding

Witch Doctors And Stents (BSX)(JNJ)

Monday’s Top Biotech and Medical Stocks

Amphastar and Teva Prevail Over Aventis, May Still Not Receive FDA Approval

Onyx Pharma Soars on Liver Cancer Drug

Raggedy Ann and the Anti-Vaccination Movement

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

Poppi’s Allison Ellsworth: ‘We Did $100,000 While We Were Sleeping’ From 1 TikTok Video

Kevin Warsh Says Good Riddance. After Powell Goes, He Wants a Transformed Fed — the Market May Not Like It

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

Poppi’s Allison Ellsworth: ‘We Did $100,000 While We Were Sleeping’ From 1 TikTok Video

Health and Healthcare Articles

All Health and Healthcare Articles

Osiris: Promising Stem Cell Research, Questionable Management

Friday’s Top Biotech and Medical Stocks

Thursday’s Top Biotech and Medical Stocks

IPO Filing: NovaBay Pharmaceuticals

Amgen And Genentech: Can Clinton Do What Competition Could Not?

Wednesday’s Top Biotech and Medical Stocks

Tuesday’s Top Biotech and Medical Stocks

Are NovaDel and Pfizer Collaborating on a Viagra Spray?

Illumina’s Double Play (Revise)

Don’t Expect Express Scripts to Bow Out of Caremark Bidding

Witch Doctors And Stents (BSX)(JNJ)

Monday’s Top Biotech and Medical Stocks

Amphastar and Teva Prevail Over Aventis, May Still Not Receive FDA Approval

Onyx Pharma Soars on Liver Cancer Drug

Raggedy Ann and the Anti-Vaccination Movement

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

Poppi’s Allison Ellsworth: ‘We Did $100,000 While We Were Sleeping’ From 1 TikTok Video

Kevin Warsh Says Good Riddance. After Powell Goes, He Wants a Transformed Fed — the Market May Not Like It

Featured Reads

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients